14 results on '"Sirdaarta, Joseph"'
Search Results
2. An examination of the Antimicrobial and Anticancer Properties of Khaya senegalensis (Desr.) A. Juss. Bark Extracts.
- Author
-
Rabadeaux, Camille, Vallette, Lou, Sirdaarta, Joseph, Davis, Craig, and Cock, Ian Edwin
- Subjects
ANTI-infective agents ,ANTINEOPLASTIC agents ,KHAYA ,PLANT extracts ,BARK - Abstract
Background: Khaya senegalensis (Desr.) A. Juss. is a common component of the pharmacopeia's of multiple African groupings which inhabit the areas in which it grows. Amongst these groups there is a myriad of medicinal uses in the treatment of a wide variety of bacterial, fungal and protozoal infections, as well as in the treatment of cancers. This study was undertaken to test K. senegalensis bark extracts for the ability to inhibit microbial and cancer cell growth, and thus to validate traditional African medicinal usage of this plant in treating a variety of diseases. Materials and Methods: K. senegalensis bark powder was extracted by both solvent maceration and subcritical fluid extraction (SFE). The extracts were tested for the ability to inhibit bacterial and G. duodenalis growth. Inhibition of Caco-2 and HeLa cancer cells was evaluated using MTS-based colorimetric cell proliferation assays. Toxicity was evaluated using an Artemia franciscana nauplii bioassay and GC-MS headspace analysis was used to identify phytochemical components. Results: K. senegalensis bark extracts displayed strong inhibitory activity against bacterial triggers of several autoimmune inflammatory diseases. The growth inhibitory activity of the methanolic and subcritical extracts was particularly noteworthy against P. mirabilis (MIC values of 185 and 211µg/mL, respectively against the reference strains). These extracts were similarly potent growth inhibitors of K. pneumoniae and A. baylyi, and were moderate inhibitors (MIC >1000µg/mL) of P. aeruginosa and S. pyogenes growth. The methanolic and subcritical K. senegalensis extracts were also potent inhibitors of G. duodenalis (187 and 328µg/mL, respectively), as well as Caco-2 (268 and 470µg/mL, respectively) and HeLa carcinomas (155 and 174µg/mL, respectively). GC-MS analysis of the SFE extract revealed relative abundances of a variety of mono- and sesquiterpenoids. Furthermore, all K. senegalensis bark extracts were non-toxic in the Artemia franciscana toxicity assay, indicating their safety for therapeutic use. Conclusion: These studies validate traditional African therapeutic usage of K. senegalensis in the treatment of microbial infections, autoimmune inflammatory diseases and some cancers. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
3. GC-MS Headspace Analysis of Terminalia ferdinandiana fruit and Leaf Extracts which inhibit Bacillus anthracis Growth.
- Author
-
Wright, Mitchell Henry, Sirdaarta, Joseph, White, Alan, Greene, Anthony Carlson, and Cock, Ian Edwin
- Subjects
- *
GAS chromatography/Mass spectrometry (GC-MS) , *TERMINALIA , *MEDICINAL plants , *BACILLUS anthracis , *BACTERIAL growth , *THERAPEUTICS ,THERAPEUTIC use of plant extracts - Abstract
Background: Terminalia ferdinandiana (Kakadu plum) is an endemic Australian plant with an extremely high antioxidant capacity. The fruit has long been used by the first Australians as a nutritional food and as a medicine and recent studies have reported its potent growth inhibitory activity against a broad panel of bacteria. Despite this, T. ferdinandiana extracts are yet to be tested for the ability to inhibit the growth of Bacillus anthracis. Materials and Methods: Solvent extracts were prepared using both the fruit and leaf of Kakadu plum. The ability to inhibit the growth of B. anthracis was investigated using a disc diffusion assay. Their MIC values were determined to quantify and compare their efficacies. Toxicity was determined using the Artemia franciscana nauplii bioassay. The most potent extracts were investigated using non-targeted GC-MS head space analysis (with screening against a compound database) for the identification and characterisation of individual components in the crude plant extracts. Results: Solvent extractions of T. ferdinandiana fruit and leaf displayed good growth inhibitory activity in the disc diffusion assay against B. anthracis. Fruit ethyl acetate and methanolic leaf extracts were particularly potent growth inhibitors, with MIC values of 451 and 377 µg/mL respectively. The fruit methanolic and chloroform extracts, as well as the aqueous leaf extracts also were good inhibitors of B. anthracis growth, albeit with lower efficacy (MIC values of 1800 and 1414 µg/mL respectively). The aqueous fruit extract and leaf chloroform extracts had only low inhibitory activity. All other extracts were completely devoid of growth inhibitory activity. Furthermore, all of the extracts with growth inhibitory activity were nontoxic in the Artemia fransiscana bioassay, with LC50 values >1000 µg/mL. Non-biased GC-MS phytochemical analysis of the most active extracts (fruit ethyl acetate and methanolic leaf) putatively identified and highlighted several compounds that may contribute to the ability of these extracts to inhibit the growth of B. anthracis. Conclusions: The low toxicity of the T. ferdinandiana fruit ethyl acetate and methanolic leaf extracts, as well as their potent growth inhibitory bioactivity against B. anthracis, indicates their potential as medicinal agents in the treatment and prevention of anthrax. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
4. An upscaled extraction protocol for Tasmannia lanceolata (Poir.) A.C. Sm.: Anti-bacterial, anti-Giardial and anticancer activity.
- Author
-
Vallette, Lou, Rabadeaux, Camille, Sirdaarta, Joseph, Davis, Craig, and Cock, Ian Edwin
- Subjects
PEPPER (Spice) ,SUPERCRITICAL fluid extraction ,ANTIBACTERIAL agents ,BOTANICAL chemistry ,ANTINEOPLASTIC agents ,POLYGODIAL - Abstract
Background: Tasmannia lanceolata is an endemic Australian plant with a high anti-oxidant capacity. Liquid solvent extractions of T. lanceolata inhibit bacterial growth and block proliferation of several carcinomas and the gastrointestinal parasite Giardia duodenalis. Despite these promising therapeutic properties, methods for the rapid extraction of large quantities of T. lanceolata are lacking. This study aimed to develop a rapid supercritical extraction method to produce extracts which retain therapeutic propertyes and phytochemistry characteristics. Materials and Methods: T. lanceolata fruit and leaf were extracted by both solvent maceration extraction and supercritical fluid extraction (SFE). The extracts were tested for the ability to inhibit bacterial and G. duodenalis growth. Inhibition of CaCo2 and HeLa cancer cells was evaluated using MTS-based colorimetric cell proliferation assays. Toxicity was evaluated using an Artemia franciscana nauplii bioassay and GC-MS headspace analysis was used to evaluate phytochemical similarity between the extracts. Results: T. lanceolata berry and leaf SFEs displayed strong bacterial growth inhibitory activity against bacterial triggers of autoimmune inflammatory diseases, with efficacies similar to the smaller scale liquid solvent extractions. The growth inhibition of the berry SFE was particularly noteworthy against P. mirabilis and K. pneumoniae, with MIC values of approximately 160 and 190 μg/mL, respectively. The berry and leaf SFE extracts also had similar antiproliferative potencies against G. duodenalis (492 and 375 μg/mL, respectively), CaCo2 (4133 and 3347 μg/mL, respectively) and HeLa carcinomas (2652 and 3497 μg/mL, respectively) to those determined for the corresponding liquid solvent extractions. GC-MS analysis of the berry SFE revealed similar terpenoid components and similar abundances to those in liquid solvent berry extraction. Furthermore, all SFEs were either non-toxic or of only low toxicity in the Artemia franciscana toxicity assay. Conclusion: The T. lanceolata SFE retained the tested therapeutic properties, were non-toxic and had similar phytochemical profiles as smaller scale liquid solvent extractions. Thus, SFE is a viable method of rapidly extracting large masses of T. lanceolata plant material to produce quality extracts which retain therapeutic properties. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
5. An Evaluation of the Antibacterial, Anti-Giardial, Anticancer and Toxicity Properties of Selected Nut Extracts.
- Author
-
Lebaratoux, Pauline, Sirdaarta, Joseph, Rayan, Paran, McDonnell, Pauline Ann, and Cock, Ian Edwin
- Subjects
- *
ANTIBACTERIAL agents , *ANTINEOPLASTIC agents , *NUTS , *PLANT extracts , *FATTY acids , *BACTERIAL growth - Abstract
Background: Foods with high oil and fatty acid contents have been linked with a variety of medicinal properties including bacterial growth inhibition, anti-Giardial activity and the inhibition of cancer cell proliferation. Almond, cashew, hazelnut and walnut contain very high fatty acid contents. Despite this, these nuts have not been adequately screened for medicinal properties. Materials and Methods: Almond, cashew, hazelnut and walnut powders were extracted and tested for antimicrobial activity using modified disc diffusion and MIC methods. Inhibitory activity against the gastrointestinal protozoal parasite Giardia duodenalis and against CaCo2 cancer cells were evaluated using colorimetric cell proliferation assays. Toxicity was evaluated using an Artemia franciscana nauplii bioassay. Results: The methanolic almond and walnut solvent extractions displayed broad spectrum growth inhibitory activity, inhibiting the growth of 100% and 7 of the 11 (64%) bacterial strains tested respectively. The methanolic walnut extract was a particularly potent growth inhibitor, with MIC values of ~1000 μg/mL, 700 μg/mL and 800 μg/mL against A. baylyi, P. mirabilis and P. vulgaris respectively. The methanolic almond extract also had moderate to inhibitory activity against E. coli (MIC ~2000 μg/mL), P. mirabilis and P. vulgaris (both ~2500 μg/mL). The methanolic cashew and hazelnut extracts were moderate inhibitors of E. coli growth (~2500 and 1250 μg/mL respectively). The methanolic almond extract was also a potent inhibitor of G. duodenalis proliferation (IC50 878 μg/mL). All extracts were ineffective at blocking the growth of the colorectal cancer cell line CaCo2. Instead, most of the extracts substantially stimulated proliferation. All of the nut extracts were non-toxic in the Artemia nauplii bioassay. Conclusion: The bacterial growth inhibitory activities of the methanolic almond and walnut extracts, the anti-Giardial activity of the methanolic almond extract and their lack of toxicity indicates the potential of these extracts in the discovery and development of new natural antibiotic agents. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
6. Cakile maritima Scop. extracts inhibit the growth of some bacterial triggers of autoimmune diseases: GC-MS analysis of an inhibitory extract.
- Author
-
Omer, Elsayed, Elshamy, Abdelsamed, El Gendy, Abdel Nasser, Xin Cai, Sirdaarta, Joseph, White, Alan, and Cock, Ian Edwin
- Subjects
MATERIA medica ,AUTOIMMUNITY ,AUTOANTIBODIES ,IMMUNOLOGIC diseases ,ANTIOXIDANTS - Abstract
Introduction: High antioxidant capacities have been linked to the treatment of rheumatic diseases and also in the inhibition of microbial growth. Although Cakile maritima has a high antioxidant capacity, it is yet to be tested for the ability to inhibit the growth of the bacterial triggers of autoimmune inflammatory diseases. Methods: C. maritima solvent extracts were analysed for antioxidant capacity by the DPPH free radical scavenging assay. Growth inhibitory activities against bacterial species associated with initiating rheumatoid arthritis, ankylosing spondylitis and multiple sclerosis were determined by disc diffusion assay and quantified by MIC determination. Toxicity was determined by Artemia franciscana bioassay. Results: All C. maritima solvent extracts displayed good DPPH radical scavenging activity, although the ethyl acetate extract was particularly potent with an IC
50 values of 3.4 μg/mL. The other extracts also had significant radical scavenging activity, with IC50 between 4.7 and 13.6 μg/mL. The bacterial growth inhibitory activity of the extracts correlated with their free radical scavenging activity. The ethyl acetate extract displayed the most potent growth inhibitory activity against most bacterial species. This extract was particularly potent against Proteus mirabilis, Proteus vulgaris and Pseudomonas aeruginosa (MIC values of 431, 559 and 777 μg/mL, respectively). The hexane extract was also a potent inhibitor of the Proteus spp., (MIC of approximately 500-800 μg/mL). The ethyl acetate extract also inhibited Klebsiella pneumoniae growth, albeit with higher MIC's (approximately 1500 μg/mL). All other C. maritima extract-bacteria combinations generally resulted in mid-low potency inhibition. All of the extracts were determined to be nontoxicin with the Artemia franciscana bioassay, with LC50 values substantially >1000 μg/mL. A total of 97 unique mass signals were detected in the C. maritima ethyl acetate extract by nonbiased GC-MS headspace analysis. A number of terpenoids which may contribute to the therapeutic bioactivities of the extract were putatively identified. Conclusion: The lack of toxicity and the inhibitory activity against microbial triggers of rheumatoid arthritis, ankylosing spondylitis and multiple sclerosis by the C. maritima ethyl acetate extract indicates its potential in the treatment and prevention of these diseases. [ABSTRACT FROM AUTHOR]- Published
- 2016
- Full Text
- View/download PDF
7. Bioactive constituents of Terminalia ferdinandiana Exell: A pharmacognistic approach towards the prevention and treatment of yersiniosis.
- Author
-
Wright, Mitchell Henry, Jean Arnold, Megan Sarah, Aldosary, Huda, Sirdaarta, Joseph, Greene, Anthony Carlson, and Cock, Ian Edwin
- Subjects
TERMINALIA ,PHARMACOGNOSY ,YERSINIA diseases ,GASTROINTESTINAL disease treatment ,PREVENTION ,THERAPEUTICS - Abstract
Introduction: Yersinia enterocolitica is a facultatively anaerobic gram negative bacterium which contaminates meat products causing the acute gastrointestinal disease yersiniosis. Terminalia ferdinandiana (Kakadu plum, gubinge) is an Australian fruit with an extremely high antioxidant capacity. It was used therapeutically by the first Australians and has documented antiseptic properties against an extensive panel of bacteria. Despite this, it has not been tested for the ability to inhibit the growth of Y. enterocolitica. Methods: T. ferdinandiana fruit and leaf extracts were extracted by maceration and the extracts were investigated by disc diffusion assay for growth inhibitory activity against a clinical strain of Y. enterocolitica. The MIC values of the extracts were determined to quantify and compare their efficacies. Toxicity was determined using the Artemia franciscana nauplii bioassay. The most potent extracts were investigated using non-targeted GC-MS analysis (with screening against a compound database) for the identification and characterisation of individual components in the crude plant extracts. Results: Solvent extractions of T. ferdinandiana leaf and fruit displayed good growth inhibitory activity in the disc diffusion assay against Y. enterocolitica. The methanolic T. ferdinandiana leaf and fruit extracts, as well as the fruit ethyl acetate extract, were particularly potent growth inhibitors, with MIC values of 372, 123 and 285 μg/mL respectively. The aqueous and ethyl acetate leaf extracts also displayed good growth inhibitory activity against Y. enterocolitica, albeit with higher MIC values (588 and 1100 μg/mL respectively). All other extracts were either low efficacy, or completely devoid of growth inhibitory activity. All T. ferdinandiana leaf and fruit extracts were either nontoxic (LC
50 values <1000 μg/mL) or of low toxicity in the Artemia franciscana bioassay. Non-biased GC-MS phytochemical analysis of the methanolic extracts putatively identified and highlighted several compounds that may contribute to the ability of these extracts to inhibit the growth of Y. enterocolitica. Conclusion: The lack of toxicity and the potent growth inhibitory bioactivity of the T. ferdinandiana fruit and leaf methanolic extracts against Y. enterocolitica indicates their potential as medicinal agents in the treatment and prevention of yersiniosis. [ABSTRACT FROM AUTHOR]- Published
- 2016
- Full Text
- View/download PDF
8. GC-MS Analysis of Commiphora molmol Oleo-Resin Extracts which Inhibit the growth of Bacterial Triggers of Selected Autoimmune Diseases.
- Author
-
Biggs, Isaac, Sirdaarta, Joseph, White, Alan, and Cock, Ian Edwin
- Abstract
Introduction: Myrrh has been used traditionally for the inhibition of microbial growth and for the treatment of rheumatic diseases. Despite this, myrrh extracts are yet to be tested for the ability to inhibit the growth of the bacterial triggers of autoimmune inflammatory diseases. Methods: Solvent extracts prepared from commercially obtained myrrh resin were analysed for the ability to inhibit the growth of bacterial species associated with initiating rheumatoid arthritis (P. mirabilis), ankylosing spondylitis (K. pneumoniae) and multiple sclerosis (A. baylyi, P. aeruginosa) by disc diffusion assay, and quantified by MIC determination. Toxicity was determined by Artemia franciscana bioassay. The most potent inhibitory extract was investigated using non-targeted GC-MS head space analysis (with screening against a compound database) for the identification and characterisation of individual components in the crude plant extracts. Results: Methanolic myrrh extract inhibited the growth of all bacterial species tested. The growth inhibition of this extract was particularly notable against P. mirabilis and K. pneumoniae, with MIC values substantially < 1000 µg/mL for both reference and clinical bacterial strains. Indeed, the MIC values of the methanolic extract against P. mirabilis reference and clinical strains were 572 and 463 µg/mL respectively. The methanolic extract also inhibited the growth of A. baylyi (MIC approximately 3000 µg/mL) and P. aeruginosa (MIC approximately 1800 µg/mL). However, the MICs against these bacteria was indicative of only moderate inhibitory activity. The aqueous, ethyl acetate, chloroform and hexane extracts also inhibited the growth of all bacterial species, albeit with moderate (MIC values 1000-5000 µg/mL) to low efficacy (MIC values >5000 µg/mL) against all bacterial species. All myrrh extracts were non-toxicin the Artemia franciscana bioassay, with LC50 values substantially above 1000 µg/mL. Non-biased GC-MS headspace analysis of the methanolic extracti dentified a high diversity of monoterpenoids and sesquiterpenoid. Conclusion: The lack of toxicity and the inhibitory activity of the methanolic myrrh extract against microbial triggers of rheumatoid arthritis, ankylosing spondylitis and multiple sclerosis indicates its potential in the treatment and prevention of these diseases. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
9. Bacillus anthracis growth Inhibitory Properties of Australian Terminalia spp.: Putative Identification of low Polarity Volatile Components by GC-MS Headspace Analysis.
- Author
-
Wright, Mitchell Henry, Sirdaarta, Joseph, White, Alan, Greene, Anthony Carlson, and Cock, Ian Edwin
- Subjects
- *
BACILLUS anthracis , *TERMINALIA , *PLANT growth inhibiting substances , *PLANT chemical analysis , *PHYTOCHEMICALS , *PLANT metabolites , *GAS chromatography/Mass spectrometry (GC-MS) , *THERAPEUTICS - Abstract
Introduction: Anthrax is a severe acute disease caused by Bacillus anthracis infections. If untreated, it often results in mortality. Many Terminalia spp. have documented therapeutic properties as general antiseptics, inhibiting the growth of a wide variety of bacterial species. This study examines the ability of selected Australian Terminalia spp. extracts to inhibit B. anthracis growth. Methods:Solvent extracts were prepared from Terminalia carpentariae and Terminalia grandiflora plant material and investigated by disc diffusion assay for the ability to inhibit the growth of an environmental strain of B. anthracis. Their MIC values were determined to quantify and compare their efficacies. Toxicity was determined using the Artemia franciscana nauplii bioassay. The most potent extracts were analysed by GC-MS headspace analysis. Results: T. carpentariae and T. grandiflora leaf, fruit and nut solvent extractions displayed good growth inhibitory activity against B. anthracis. Methanolic T. carpentariae leaf and T. grandiflora nut extracts were particularly potent growth inhibitors, with MIC values of 74 and 155 µg/mL respectively. The T. carpentariae leaf ethyl acetate extract was also a good inhibitor of B. anthracis growth (MIC 340 µg/mL). All other extracts were substantially less potent growth inhibitors. Interestingly, the T. carpentariae leaf extracts with growth inhibitory activity were nontoxic in the Artemia fransiscana bioassay, with LC50 values >1000 µg/mL. In contrast, the LC50 value 740 µg/mL reported for the methanolic T. grandiflora nut extract indicates low-moderate toxicity. Non-biased GC-MS phytochemical analysis of the most active extracts (methanolic T. carpentariae leaf and T. grandiflora nut) putatively identified and highlighted several compounds that may contribute to the ability of these extracts to inhibit the growth of B. anthracis. Conclusion: The growth inhibitory activity of the methanolic T. carpentariae leaf and T. grandiflora nutextracts against B. anthracis indicates their potential for the treatment and prevention of anthrax. Furthermore, the lack toxicity of the T. carpentariae leaf and the low-moderate toxicity of the T. grandiflora nut extract, indicates that their use may extend to all forms of the disease (cutaneous, inhalation or gastrointestinal). [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
10. High Performance Liquid Chromatography-mass Spectrometry Analysis of High Antioxidant Australian Fruits with Antiproliferative Activity Against Cancer Cells.
- Author
-
Sirdaarta, Joseph, Maen, Anton, Rayan, Paran, Matthews, Ben, and Cock, Ian Edwin
- Subjects
- *
HIGH performance liquid chromatography , *MASS spectrometry , *FRUIT testing , *FRUIT , *CANCER cells , *CANCER treatment , *THERAPEUTICS - Abstract
Background: High antioxidant capacities have been linked to the treatment and prevention of several cancers. Recent reports have identified several native Australian fruits with high antioxidant capacities. Despite this, several of these species are yet to be tested for anticancer activity. Materials and Methods: Solvent extracts prepared from high antioxidant native Australian fruits were analyzed for antioxidant capacity by the di (phenyl)-(2,4,6-trinitrophenyl) iminoazanium free radical scavenging assay. Antiproliferative activities against CaCo2 and HeLa cancer cells were determined by a multicellular tumor spheroid-based cell proliferation assay. Toxicity was determined by Artemia franciscana bioassay. Results: Methanolic extracts of all plant species displayed high antioxidant contents (equivalent to approximately 7-16 mg of vitamin C per gram of fruit extracted). Most aqueous extracts also contained relatively high antioxidant capacities. In contrast, the ethyl acetate, chloroform, and hexane extracts of most species (except lemon aspen and bush tomato) had lower antioxidant contents (below 1.5 mg of vitamin C equivalents per gram of plant material extracted). The antioxidant contents correlated with the ability of the extracts to inhibit proliferation of CaCo2 and HeLa cancer cell lines. The high antioxidant methanolic extracts of all species were potent inhibitors of cell proliferation. The methanolic lemon aspen extract was particularly effective, with IC50 values of 480 and 769 μg/mL against HeLa and CaCo2 cells, respectively. In contrast, the lower antioxidant ethyl acetate and hexane extracts (except the lemon aspen ethyl acetate extract) generally did not inhibit cancer cell proliferation or inhibited to only a minor degree. Indeed, most of the ethyl acetate and hexane extracts induced potent cell proliferation. The native tamarind ethyl acetate extract displayed low-moderate toxicity in the A. franciscana bioassay (LC50 values below 1000 μg/mL). All other extracts were nontoxic. A total of 145 unique mass signals were detected in the lemon aspen methanolic and aqueous extracts by nonbiased high-performance liquid chromatography-mass spectrometry analysis. Of these, 20 compounds were identified as being of particular interest due to their reported antioxidant and/or anticancer activities. Conclusions: The lack of toxicity and antiproliferative activity of the high antioxidant plant extracts against HeLa and CaCo2 cancer cell lines indicates their potential in the treatment and prevention of some cancers. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
11. Growth inhibitory activity of kakadu Plum extracts against the opportunistic pathogen Clostridium perfringens: New leads in the prevention and treatment of clostridial myonecrosis.
- Author
-
Wright, Mitchell Henry, Sirdaarta, Joseph, Matthews, Ben, Greene, Anthony Carlson, and Cock, Ian Edwin
- Subjects
- *
PLANT extracts , *CLOSTRIDIAL enteritis , *CLOSTRIDIUM perfringens , *PLUM , *HIGH performance liquid chromatography , *THERAPEUTICS - Abstract
Introduction: Clostridium perfringens is the etiological agent of clostridial myonecrosis and enteritis necroticans. Infections result in exotoxin production, tissue necrosis and unless promptly treated, may result in death. Terminalia ferdinandiana (Kakadu plum) fruit has documented therapeutic properties as a general antiseptic agent. Fruit extracts have been reported to inhibit the growth of an extensive panel of pathogenic bacteria. Leaf extracts have also been shown to block the growth of several bacterial species associated with autoimmune inflammatory diseases. Methods: T. ferdinandiana fruit and leaf solvent extracts were investigated for growth inhibitory activity by disc diffusion assay against a clinical strain of Clostridium perfringens. Their MIC values were determined to quantify and compare their efficacies. Toxicity was determined using the Artemia franciscana nauplii bioassay. Active extracts were analysed by non-targeted HPLC-QTOF mass spectroscopy (with screening against 3 compound databases) for the identification and characterisation of individual components in the crude plant extracts. Results: Methanolic and aqueous T. ferdinandiana fruit and leaf extracts, as well as the leaf ethyl acetate extract, displayed growth inhibitory activity in the disc diffusion assay against C. perfringens. The leaf extracts were generally more potent growth inhibitors than the corresponding fruit extracts, although the aqueous fruit extract had substantially greater efficacy than the aqueous leaf extract. The methanolic and ethyl acetate leaf extracts were particularly potent growth inhibitors, with MIC values of 206 and 117 µg/ml respectively. The fruit methanolic extract also displayed good efficacy, with an MIC of 716 µg/ml. In contrast, the chloroform and hexane extracts of both fruit and leaf were completely devoid of growth inhibitory activity. All T. ferdinandiana extracts were either nontoxic or of low toxicity in the Artemia fransiscana bioassay. Non-biased phytochemical analysis of the methanolic and ethyl acetate leaf extracts revealed the presence of high relative levels of a diversity of galloand ellagi- tannins. Conclusion: The low toxicity of the T. ferdinandiana extracts and the potent growth inhibitory bioactivity of the leaf methanolic and ethyl acetate extracts against C. perfringens indicates their potential as medicinal agents in the treatment and prevention of clostridial myonecrosis and enteritis necroticans. Metabolomic profiling studies indicate that these extracts contained a diversity of tannins. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
12. GC-MS Analysis of Frankincense Extracts which Inhibit the Growth of Bacterial Triggers of Selected Autoimmune Diseases.
- Author
-
Biggs, Isaac, Sirdaarta, Joseph, White, Alan, and Cock, Ian Edwin
- Subjects
- *
FRANKINCENSE , *AUTOIMMUNE disease treatment , *MICROBIAL growth , *BOSWELLIA , *MONOTERPENES , *PREVENTION - Abstract
Introduction: Frankincense has been used traditionally for the inhibition of microbial growth and for the treatment of rheumatic diseases. Despite this, frankincense extracts are yet to be tested for the ability to inhibit the growth of the bacterial triggers of autoimmune inflammatory diseases. Methods: Solvent extracts prepared from commercially obtained frankincense were analysed for the ability to inhibit the growth of bacterial species associated with initiating rheumatoid arthritis (P. mirabilis), ankylosing spondylitis (K. pneumoniae) and multiple sclerosis (A. baylyi, P. aeruginosa) by disc diffusion assay, and quantified by MIC determination. Toxicity was determined by Artemia franciscana bioassay.The most potent inhibitory extracts were investigated using non-targeted GC-MS head space analysis (with screening against a compound database) for the identification and characterisation of individual components in the crude plant extracts. Results: Methanolic and aqueous frankincense extracts inhibited the growth of all bacterial species. The growth inhibition of these extracts was particularly notable against P. mirabilis and K. pneumoniae, with MIC values generally ⩽ 1000 μg/mL for both reference and clinical bacterial strains. Indeed, the MIC values of the methanolic extract against P. mirabilis, and for the aqueous extract against K. pneumonia, were as low as 59.6 and 75.2 μg/mL respectively. The methanolic and aqueous extracts also inhibited the growth of A. baylyi and P. aeruginosa. However, with the exception of the growth inhibition of A. baylyi by the aqueous extract (MIC=4313 μg/mL: moderate inhibitory activity), the MICs against these bacteria was indicative of only low inhibitory activity. The ethyl acetate, chloroform and hexane extracts also inhibited the growth of all bacterial species, albeit with low efficacy (MIC values generally >5000 μg/mL against all bacterial species). All frankincense extracts were non-toxic in the Artemia franciscana bioassay, with LC50 values substantially above 1000 μg/mL. Non-biased GC-MS headspace analysis of the methanolic and aqueous extracts putatively identified a high diversity of monoterpenoids and sesquiteriterpenoids. Conclusion: The lack of toxicity and the inhibitory activity of the methanolic and aqueous frankincense extracts against microbial triggers of rheumatoid arthritis and ankylosing spondylitis indicates their potential in the treatment and prevention of these diseases. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
13. GC-MS and LC-MS analysis of Kakadu plum fruit extracts displaying inhibitory activity against microbial triggers of multiple sclerosis.
- Author
-
Sirdaarta, Joseph, Matthews, Ben, White, Alan, and Cock, Ian Edwin
- Subjects
- *
TERMINALIA , *MULTIPLE sclerosis treatment , *ACINETOBACTER , *THERAPEUTICS - Abstract
Introduction: Multiple sclerosis is an autoimmune disease which can be triggered in genetic susceptible individuals by Acinetobacter spp. and Pseudomonas aeruginosa infections. Terminalia ferdinandiana (Kakadu plum) fruit has documented therapeutic properties as a general antiseptic agent. Extracts prepared from the leaves have also been shown to block several microbial triggers of autoimmune inflammatory diseases. This study examines the ability of Kakadu plum fruit extracts to inhibit some microbial triggers of multiple sclerosis. Methods: T. ferdinandiana fruit solvent extracts were investigated by disc diffusion assay against reference and clinical strains of A.baylyi and P. aeruginosa. Their MIC values were determined to quantify and compare their efficacies. Toxicity was determined using the Artemia franciscana nauplii bioassay. Active extracts were analysed by non-targeted HPLC-QTOF mass spectroscopy (with screening against 3 compound databases) and by GC-MS (with screening against 1 compound databases) for the identification and characterisation of individual components in crude plant extracts. Results: Methanolic, aqueous and ethyl acetate T. ferdinandiana leaf extracts displayed potent antibacterial activity in the disc diffusion assay against the bacterial triggers of multiple sclerosis (A.baylyi and P. aeruginosa). The methanol and ethyl acetate extracts had the most potent growth inhibitory activity, with MIC values less than 1000 µg/ml against A. baylyi and P. aeruginosa (both reference and clinical strains). In comparison, the water extract was substantially less potent. Neither the chloroform nor hexane extracts inhibited the growth of any of the bacterial strains tested. All T. ferdinandiana fruit extracts were nontoxic in the Artemia fransiscana bioassay. Non-biased phytochemical analysis of the ethyl acetate extract revealed only low levels of the tannins gallic acid and chebulic acid and no other tannins. Conclusion: The low toxicity of the T. ferdinandiana fruit extracts and their potent inhibitory bioactivity against the bacterial triggers of multiple sclerosis indicates their potential as medicinal agents in the treatment and prevention of this disease. Phytochemical studies indicate that this activity is likely to be due to phytochemicals other than tannins. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
14. Yellow-Emitting Carbon Nanodots and Their Flexible and Transparent Films for White LEDs.
- Author
-
Kim TH, White AR, Sirdaarta JP, Ji W, Cock IE, St John J, Boyd SE, Brown CL, and Li Q
- Abstract
We report carbon nanodots that can be utilized as effective color converting phosphors for the production of white light-emitting diodes (LEDs). Blue-excitable and yellow-emitting carbon nanodots, functionalized with 3-(imidazolidin-2-on-1-yl)propylmethyldimethoxysilane (IPMDS)-derived moieties (IS-CDs), are synthesized by a novel one-pot reaction in which the products from the initial reaction occurring between urea and 3-(2-aminoethylamino)propylmethyl-dimethoxysilane (AEPMDS) are further treated with citric acid. Distinctive from the majority of carbon nanodots reported previously, IS-CDs emit at 560 nm, under 460 nm excitation, with a quantum yield of 44%. Preliminary toxicity studies, assessed by the Artemia franciscana nauplii (brine shrimp larvae) bioassay, indicate that IS-CDs are largely nontoxic. Furthermore, the IS-CDs form flexible and transparent films without the need of encapsulating agents, and the solid films retain the optical properties of solvated IS-CDs. These features indicate an immense potential for the IS-CDs as an environmental-friendly, blue-excitable carbon nanodot-based phosphor in solid-state lighting devices.
- Published
- 2016
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.